STOCK TITAN

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Rhea-AI Summary

Maravai LifeSciences, Inc. (NASDAQ: MRVI) will announce its third quarter 2022 financial and operational results on November 2, 2022, after market close. The company will also host a conference call at 2:00 PM PT/5:00 PM ET on the same day. Maravai specializes in critical life science products that support drug therapy development, diagnostics, and vaccine innovation. Their solutions are vital for research in human diseases and serve leading biopharmaceutical and gene therapy firms.

Loading...
Loading translation...

Positive

  • Leading position in life sciences with a focus on drug therapies, diagnostics, and vaccine development.

Negative

  • None.

News Market Reaction 1 Alert

-13.18% News Effect

On the day this news was published, MRVI declined 13.18%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2022 financial and operating results after the market closes on Wednesday, November 2, 2022, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

To participate in the conference call by telephone, dial (877) 315-3037 or (201) 689-8357 and reference Maravai LifeSciences. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.

About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.

Contact Information:
Media Contact: Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macdougall.bio

Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com


FAQ

When will Maravai LifeSciences report its Q3 2022 financial results?

Maravai LifeSciences will report its Q3 2022 financial results on November 2, 2022.

What time is the Maravai LifeSciences conference call on November 2, 2022?

The conference call for Maravai LifeSciences will take place at 2:00 PM PT/5:00 PM ET on November 2, 2022.

How can I access the Maravai LifeSciences conference call?

You can access the conference call by dialing (877) 315-3037 or (201) 689-8357, or through the live or archived webcast on their Investors section of the website.
Maravai Lifesciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Latest SEC Filings

MRVI Stock Data

471.32M
106.33M
10.16%
90.18%
9.59%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO